Upregulation of MiR-1254 Promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion Via Inactivation of the Hippo-YAP Signaling Pathway by Decreasing PAX5
Affiliations
Increasing evidence suggests that microRNAs (miRNAs) affect the progression of hepatocellular carcinoma (HCC). However, the exact function and mechanism of miR-1254 in HCC remains unclear. This study explored the effects of miR-1254 on the biological behavior of HCC cells and determined the underlying mechanism. RT-qPCR was used to detect the expression of miR-1254. Gain- or loss-of-function assays determined if miR-1254 affected the biological function of HCC cells . Dual luciferase reporter assays confirmed the target gene of miR-1254. Tumor xenografts in mice were used to explore the effects of miR-1254 on tumorigenesis and metastasis of HCC. miR-1254 was upregulated in HCC tissues and cell lines and linked to larger tumor size, aggressive vascular invasion and higher Edmondson grade. Lentiviral-based overexpression and knockdown experiments indicated that miR-1254 promoted proliferation, migration, invasion, and the epithelial-mesenchymal transition of HCC cells. The paired box gene 5 (PAX5) was downregulated in HCC tissues, negatively correlated with miR-1254 expression, and confirmed to be a direct target of miR-1254. Restoration of PAX5 reversed the effects of miR-1254 on the biological behavior of HCC cells. Advanced mechanism studies suggested that PAX5 might mediate miR-1254 by regulating the Hippo signaling pathway. Tumor xenografts in mice confirmed that miR-1254 promoted tumorigenesis and metastasis, and led to poor survival. In conclusion, miR-1254 promoted proliferation, migration, and invasion of HCC cells via decreasing Hippo signaling through targeting PAX5 and . This miRNA might be a therapeutic target for HCC.
Novel insights into the impact of liver inflammatory responses on primary liver cancer development.
Ait-Ahmed Y, Lafdil F Liver Res. 2025; 7(1):26-34.
PMID: 39959704 PMC: 11791919. DOI: 10.1016/j.livres.2023.01.001.
Paired Box 5 (PAX5) Gene Has Diagnostic and Prognostic Potential in Nasopharyngeal Carcinoma.
Ye J, Huang X, Qin W, Liang P, Zhao J, Ye Y Int J Gen Med. 2024; 17:487-501.
PMID: 38348125 PMC: 10860600. DOI: 10.2147/IJGM.S442835.
Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
Shi H, Zou Y, Zhong W, Li Z, Wang X, Yin Y J Cancer Res Clin Oncol. 2023; 149(16):15311-15322.
PMID: 37608027 DOI: 10.1007/s00432-023-05272-2.
Chen W, Chang T, Chou H, Cheng M, Hong J, Hsieh Y Int J Mol Sci. 2023; 24(11).
PMID: 37298699 PMC: 10253890. DOI: 10.3390/ijms24119748.
Takashima Y, Komatsu S, Ohashi T, Kiuchi J, Nishibeppu K, Kamiya H Cancer Sci. 2023; 114(7):3027-3040.
PMID: 37190912 PMC: 10323105. DOI: 10.1111/cas.15830.